ArticleMolecular cancer therapeutics2024

Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.